| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2023-02-21 17:14:27 UTC |
|---|
| HMDB ID | HMDB0000023 |
|---|
| Secondary Accession Numbers | - HMDB0000435
- HMDB00023
- HMDB00435
- HMDB0062640
- HMDB0126088
- HMDB62640
|
|---|
| Metabolite Identification |
|---|
| Common Name | (S)-3-Hydroxyisobutyric acid |
|---|
| Description | (S)-3-Hydroxyisobutyric acid (3-HIBA) (CAS: 2068-83-9) is an organic acid. 3-HIBA is an intermediate in L-valine metabolism. 3-HIBA plays an important role in the diagnosis of the very rare inherited metabolic diseases 3-hydroxyisobutyric aciduria (OMIM: 236795 ) and methylmalonic semialdehyde dehydrogenase deficiency (OMIM: 603178 ). Patients with 3-hydroxyisobutyric aciduria excrete a significant amount of 3-HIBA not only during the acute stage but also when stable. 3-Hydroxyisobutyric aciduria is caused by a 3-hydroxyisobutyryl-CoA dehydrogenase deficiency (PMID: 18329219 ). The severity of this disease varies from case to case. Most patients exhibit dysmorphic features, such as a small triangular face, a long philtrum, low set ears, and micrognathia (PMID: 10686279 ). Lactic acidemia is also found in the affected patients, indicating that mitochondrial dysfunction is involved. 3-HIBA appears to specifically inhibit the function of the respiratory chain complex I-III and mitochondrial creatine kinase (PMID: 18329219 ). BioTransformer predicts that 3-HIBA is a product of 2-methylpropanoic acid metabolism via a hydroxylation-of-terminal-methyl reaction catalyzed by CYP2B6 and CYP2E1 enzymes (PMID: 30612223 ). |
|---|
| Structure | InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (S)-3-Hydroxy-2-methylpropanoic acid | ChEBI | | (S)-3-Hydroxy-2-methylpropionic acid | ChEBI | | (S)-3-Hydroxy-2-methylpropanoate | Generator | | (S)-3-Hydroxy-2-methylpropionate | Generator | | (S)-3-Hydroxyisobutyrate | Generator | | 2-Methyl-L-(+)-hydracrylate | HMDB | | 2-Methyl-L-(+)-hydracrylic acid | HMDB | | 3-Hydroxy(iso)butyric acid | HMDB | | 3-Hydroxy-2-methyl-(S)-propanoate | HMDB | | 3-Hydroxy-2-methyl-(S)-propanoic acid | HMDB | | 3-Hydroxy-2-methylpropanoate | HMDB | | 3-Hydroxy-2-methylpropanoic acid | HMDB | | 3-Hydroxy-isobutyrate | HMDB | | 3-Hydroxyisobutyrate | HMDB | | 3-Hydroxyisobutyric acid | HMDB | | (2S)-3-Hydroxy-2-methylpropanoic acid | HMDB | | (2S)-3-Hydroxy-2-methylpropionic acid | HMDB | | (S)-beta-Hydroxyisobutyric acid | HMDB | | (S)-Β-hydroxyisobutyric acid | HMDB | | (±)-3-hydroxy-2-methylpropanoic acid | HMDB | | (±)-3-hydroxy-2-methylpropionic acid | HMDB | | 2-(Hydroxymethyl)propanoic acid | HMDB | | 2-(Hydroxymethyl)propionic acid | HMDB | | 2-Methyl-3-hydroxypropanoic acid | HMDB | | 2-Methyl-3-hydroxypropionic acid | HMDB | | 3-HIBA | HMDB | | 3-Hydroxy-2-methylpropionic acid | HMDB | | DL-3-Hydroxyisobutyric acid | HMDB | | L-(+)-beta-Hydroxyisobutyric acid | HMDB | | L-(+)-Β-hydroxyisobutyric acid | HMDB | | beta-Hydroxyisobutyric acid | HMDB | | Β-hydroxyisobutyric acid | HMDB | | 3-Hydroxy-2-isobutyrate | HMDB | | 3-Hydroxy-2-isobutyric acid | HMDB | | (S)-3-Hydroxyisobutyric acid | HMDB |
|
|---|
| Chemical Formula | C4H8O3 |
|---|
| Average Molecular Weight | 104.1045 |
|---|
| Monoisotopic Molecular Weight | 104.047344122 |
|---|
| IUPAC Name | (2S)-3-hydroxy-2-methylpropanoic acid |
|---|
| Traditional Name | (S)-3-hydroxyisobutyric acid |
|---|
| CAS Registry Number | 26543-05-5 |
|---|
| SMILES | C[C@@H](CO)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1 |
|---|
| InChI Key | DBXBTMSZEOQQDU-VKHMYHEASA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Hydroxy acids and derivatives |
|---|
| Sub Class | Beta hydroxy acids and derivatives |
|---|
| Direct Parent | Beta hydroxy acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Beta-hydroxy acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Primary alcohol
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.7 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.3202 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.82 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 207.3 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 836.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 350.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 59.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 221.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 64.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 273.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 267.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 346.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 603.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 110.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 807.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 209.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 263.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 601.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 282.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 299.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (S)-3-Hydroxyisobutyric acid,1TMS,isomer #1 | C[C@@H](CO[Si](C)(C)C)C(=O)O | 1085.9 | Semi standard non polar | 33892256 | | (S)-3-Hydroxyisobutyric acid,1TMS,isomer #2 | C[C@@H](CO)C(=O)O[Si](C)(C)C | 1020.5 | Semi standard non polar | 33892256 | | (S)-3-Hydroxyisobutyric acid,2TMS,isomer #1 | C[C@@H](CO[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1170.4 | Semi standard non polar | 33892256 | | (S)-3-Hydroxyisobutyric acid,1TBDMS,isomer #1 | C[C@@H](CO[Si](C)(C)C(C)(C)C)C(=O)O | 1328.6 | Semi standard non polar | 33892256 | | (S)-3-Hydroxyisobutyric acid,1TBDMS,isomer #2 | C[C@@H](CO)C(=O)O[Si](C)(C)C(C)(C)C | 1255.6 | Semi standard non polar | 33892256 | | (S)-3-Hydroxyisobutyric acid,2TBDMS,isomer #1 | C[C@@H](CO[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1592.3 | Semi standard non polar | 33892256 |
|
|---|
| Spectra |
|---|
| |
|---|
| Biological Properties |
|---|
| Cellular Locations | |
|---|
| Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Urine
|
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 20.0 (4.0-48.0) uM | Children (1-13 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 21.0 +/- 2.0 uM | Adult (>18 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 18.0 +/- 18.0 (0 - 36) uM | Adult (>18 years old) | Not Specified | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | 1.23 +/- 0.71 uM | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 29.0 (11.8-59.8) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 8.1-18 umol/mmol creatinine | Infant (0-1 year old) | Male | Normal | | details | | Urine | Detected and Quantified | 6.9-13.4 umol/mmol creatinine | Infant (0-1 year old) | Female | Normal | | details | | Urine | Detected and Quantified | 10.0-15.9 umol/mmol creatinine | Infant (0-1 year old) | Female | Normal | | details | | Urine | Detected and Quantified | 10-17.0 umol/mmol creatinine | Infant (0-1 year old) | Male | Normal | | details | | Urine | Detected and Quantified | <95 umol/mmol creatinine | Children (1 - 18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 13.39 +/- 6.588 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 14.5 (5.5-28.7) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | | Urine | Detected and Quantified | 11 (4.1-19) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 13.0 (2.0-24.0) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 25.4 (10.2 -33.5) umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | | Urine | Detected and Quantified | 7.8 (3.8-25.1) umol/mmol creatinine | Adolescent (13-18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 8.5 (4.9-17.1) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 38.0 +/- 5.0 uM | Adult (>18 years old) | Both | Diabetes | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Urine | Detected and Quantified | 17.5 (2.0-33.0) umol/mmol creatinine | Adult (>18 years old) | Both | 3-Hydroxyisobutyric aciduria | | details | | Urine | Detected and Quantified | 225.0 (60.0-390.0) umol/mmol creatinine | Children (1-13 years old) | Both | 3-Hydroxyisobutyric Aciduria | | details | | Urine | Detected and Quantified | 12.772 +/- 10.179 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Diabetes mellitus type 2 |
|---|
- Avogaro A, Bier DM: Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res. 1989 Nov;30(11):1811-7. [PubMed:2614280 ]
| | Colorectal cancer |
|---|
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| | 3-Hydroxyisobutyric aciduria |
|---|
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| | Eosinophilic esophagitis |
|---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
|---|
| Associated OMIM IDs | - 125853 (Diabetes mellitus type 2)
- 114500 (Colorectal cancer)
- 236795 (3-Hydroxyisobutyric aciduria)
- 610247 (Eosinophilic esophagitis)
|
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB021877 |
|---|
| KNApSAcK ID | Not Available |
|---|
| Chemspider ID | 389707 |
|---|
| KEGG Compound ID | C06001 |
|---|
| BioCyc ID | CPD-12175 |
|---|
| BiGG ID | 37034 |
|---|
| Wikipedia Link | Not Available |
|---|
| METLIN ID | 483 |
|---|
| PubChem Compound | 440873 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 37373 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | 3HMP |
|---|
| MarkerDB ID | MDB00000012 |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Robison, Robert S.; Doremus, Michael G.L-(+)-b-Hydroxyisobutyric acid by fermentation. U.S. (1986), 5 pp. |
|---|
| Material Safety Data Sheet (MSDS) | Download (PDF) |
|---|
| General References | - Yoshida I, Sweetman L, Kulovich S, Nyhan WL, Robinson BH: Effect of lipoic acid in a patient with defective activity of pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase, and branched-chain keto acid dehydrogenase. Pediatr Res. 1990 Jan;27(1):75-9. [PubMed:2104971 ]
- Liebich HM, Dotzauer A, Tetschner B: Gas chromatographic determination of oxo- and hydroxycarboxylic acids in serum and urine of diabetic and normal subjects. J Chromatogr. 1989 May 12;468:157-65. [PubMed:2732286 ]
- Podebrad F, Heil M, Beck T, Mosandl A, Sewell AC, Bohles H: Stereodifferentiation of 3-hydroxyisobutyric- and 3-aminoisobutyric acid in human urine by enantioselective multidimensional capillary gas chromatography-mass spectrometry. Clin Chim Acta. 2000 Feb 25;292(1-2):93-105. [PubMed:10686279 ]
- Chitayat D, Meagher-Villemure K, Mamer OA, O'Gorman A, Hoar DI, Silver K, Scriver CR: Brain dysgenesis and congenital intracerebral calcification associated with 3-hydroxyisobutyric aciduria. J Pediatr. 1992 Jul;121(1):86-9. [PubMed:1625099 ]
- Landaas S: Accumulation of 3-hydroxyisobutyric acid, 2-methyl-3-hydroxybutyric acid and 3-hydroxyisovaleric acid in ketoacidosis. Clin Chim Acta. 1975 Oct 15;64(2):143-54. [PubMed:126826 ]
- Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69. [PubMed:8412012 ]
- Djoumbou-Feunang Y, Fiamoncini J, Gil-de-la-Fuente A, Greiner R, Manach C, Wishart DS: BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification. J Cheminform. 2019 Jan 5;11(1):2. doi: 10.1186/s13321-018-0324-5. [PubMed:30612223 ]
- Viegas CM, da Costa Ferreira G, Schuck PF, Tonin AM, Zanatta A, de Souza Wyse AT, Dutra-Filho CS, Wannmacher CM, Wajner M: Evidence that 3-hydroxyisobutyric acid inhibits key enzymes of energy metabolism in cerebral cortex of young rats. Int J Dev Neurosci. 2008 May-Jun;26(3-4):293-9. doi: 10.1016/j.ijdevneu.2008.01.007. Epub 2008 Feb 7. [PubMed:18329219 ]
|
|---|